Compounds > 20-hydroxy-5,8,11,14-eicosatetraenoic acid
Page last updated: 2024-09-03

20-hydroxy-5,8,11,14-eicosatetraenoic acid and Cirrhosis, Liver

20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Cirrhosis, Liver in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chesnik, MA; Hye Khan, MA; Imig, JD; Kolb, LL; Skibba, M; Yeboah, MM1
Angeli, P; Balazy, M; Gatta, A; McGiff, JC; Sacerdoti, D1
Moore, K1

Other Studies

3 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Cirrhosis, Liver

ArticleYear
Role of the cytochrome P-450/ epoxyeicosatrienoic acids pathway in the pathogenesis of renal dysfunction in cirrhosis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2018, 08-01, Volume: 33, Issue:8

    Topics: Animals; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Hydroxyeicosatetraenoic Acids; Kidney Diseases; Liver Cirrhosis; Male; Rats; Rats, Sprague-Dawley; Signal Transduction

2018
Eicosanoid excretion in hepatic cirrhosis. Predominance of 20-HETE.
    The Journal of clinical investigation, 1997, Sep-01, Volume: 100, Issue:5

    Topics: Adult; Aged; Cytochrome P-450 Enzyme System; Eicosanoids; Female; Humans; Hydroxyeicosatetraenoic Acids; Liver Cirrhosis; Male; Middle Aged

1997
Cytochrome P450 products and renal function in cirrhosis: the HETE is on.
    Hepatology (Baltimore, Md.), 1998, Volume: 27, Issue:4

    Topics: Cytochrome P-450 Enzyme System; Humans; Hydroxyeicosatetraenoic Acids; Kidney; Liver Cirrhosis

1998